Generic placeholder image

Current Topics in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1568-0266
ISSN (Online): 1873-4294

Research Article

In-silico Studies and Wet-Lab Validation of Camptothecin Derivatives for Anti-Cancer Activity Against Liver (HepG2) and Lung (A549) Cancer Cell Lines

Author(s): Komal Kalani, Dharmendra K. Yadav, Sarfaraz Alam, Feroz Khan, Mahendra P. Kashyap, Santosh K. Srivastava* and Aditya B. Pant

Volume 21, Issue 10, 2021

Published on: 26 April, 2021

Page: [908 - 919] Pages: 12

DOI: 10.2174/1568026621666210426124719

Price: $65

Abstract

Background

: In the present study, we have explored the utility of QSAR modelling, in silico ADMET, docking, chemical semi-synthesis, and in vitro evaluation studies for the identification of active camptothecin (CPT) derivatives against cancer-targeting human liver (HepG2) and lung (A549) cancer cell lines.

Methods: Two QSAR models were developed as screenings tools using the multiple linear regression (MLR) method followed by ADMET and docking studies. The regression coefficient (r2) and cross-validation regression coefficients (rCV2T) of the QSAR model for the HepG2 cell line was 0.95 and 0.90, respectively, and for the A549 cell line, it was 0.93 and 0.81, respectively.

Results: In silico studies show that CPT derivatives (CPT-1 and CPT-6) possess drug-like properties. Docking performed on DNA Topoisomerase-I showed significant binding affinity. Finally, predicted active derivatives were chemically semi synthesized, spectroscopically characterized, and evaluated in-vitro for cytotoxic/anticancer activity against HepG2 and A549 cell lines.

Conclusion: The experimental results are consistent with the predicted results. These findings may be of immense importance in the anticancer drug development from an inexpensive and widely available natural product, camptothecin.

Keywords: QSAR, ADME/T, Bioavailability, Docking, Camptothecin derivatives, Anticancer, Cytotoxic.

Graphical Abstract
[1]
World cancer report: cancer research for cancer prevention. 2020. Available from: https://shop.iarc.fr/products/world-cancer-report-cancer-research-for-cancer-prevention-pdf
[2]
Protopapa, M.N.; Lagadinou, M.; Papagiannis, T.; Gogos, C.A.; Solomou, E.E. Hepatocellular carcinoma: an uncommon metastasis in the orbit. Case Rep. Oncol. Med., 2020, 2020, 7526042.
[http://dx.doi.org/10.1155/2020/7526042] [PMID: 32158574]
[3]
American Cancer Society. Liver cancer risk factors, 2016. Available from: http://www.cancer.org/cancer/livercancer/detailedguide/liver-cancer-risk-factors
[5]
Department of Health. Available from: http://www.doh.gov.tw/EN2006/index_EN.aspx
[6]
Hashibe, M.; Brennan, P.; Benhamou, S.; Castellsague, X.; Chen, C.; Curado, M.P.; Dal Maso, L.; Daudt, A.W.; Fabianova, E.; Fernandez, L.; Wünsch-Filho, V.; Franceschi, S.; Hayes, R.B.; Herrero, R.; Koifman, S.; La Vecchia, C.; Lazarus, P.; Levi, F.; Mates, D.; Matos, E.; Menezes, A.; Muscat, J.; Eluf-Neto, J.; Olshan, A.F.; Rudnai, P.; Schwartz, S.M.; Smith, E.; Sturgis, E.M.; Szeszenia-Dabrowska, N.; Talamini, R.; Wei, Q.; Winn, D.M.; Zaridze, D.; Zatonski, W.; Zhang, Z.F.; Berthiller, J.; Boffetta, P. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J. Natl. Cancer Inst., 2007, 99(10), 777-789.
[http://dx.doi.org/10.1093/jnci/djk179] [PMID: 17505073]
[7]
Parkin, D.M.; Pisani, P.; Ferlay, J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int. J. Cancer, 1999, 80(6), 827-841.
[http://dx.doi.org/10.1002/(SICI)1097-0215(19990315)80:6<827::AID-IJC6>3.0.CO;2-P] [PMID: 10074914]
[8]
Rahman, M.; Sakamoto, J.; Fukui, T. Calculation of population attributable risk for bidi smoking and oral cancer in south Asia. Prev. Med., 2005, 40(5), 510-514.
[http://dx.doi.org/10.1016/j.ypmed.2004.09.030] [PMID: 15749132]
[9]
Room, R.; Babor, T.; Rehm, J. Alcohol and public health. Lancet, 2005, 365(9458), 519-530.
[http://dx.doi.org/10.1016/S0140-6736(05)17870-2] [PMID: 15705462]
[10]
Balaram, P; Sridhar, H; Rajkumar, T; Vaccarella, S; Herrero, R; Nandakumar, A; Ravichandran, K; Ramdas, K; Sankaranarayanan, R; Gajalakshmi, V; Munoz, N; Franceschi, S Oral cancer in southern India: the influence of smoking, drinking, paan-chewing and oral hygiene. Int. J. Cancer, 2002, 98(3), 440-455.
[11]
Lee, K.H.; Lin, Y.M.; Wu, T.S.; Zhang, D.C.; Yamagishi, T.; Hayashi, T.; Hall, I.H.; Chang, J.J.; Wu, R.Y.; Yang, T.H. The cytotoxic principles of Prunella vulgaris, Psychotria serpens, and Hyptis capitata: ursolic acid and related derivatives. Planta Med., 1988, 54(4), 308-311.
[http://dx.doi.org/10.1055/s-2006-962441] [PMID: 3222376]
[12]
Lin, C.N.; Lu, C.M.; Cheng, M.K.; Gan, K.H.; Won, S.J. The cytotoxic principles of Solanum incanum. J. Nat. Prod., 1990, 53(2), 513-516.
[http://dx.doi.org/10.1021/np50068a041] [PMID: 2380724]
[13]
Jung, H.J.; Nam, J.H.; Choi, J.; Lee, K.T.; Park, H.J. 19Alpha-hydroxyursane-type triterpenoids: antinociceptive anti-inflammatory principles of the roots of Rosa rugosa. Biol. Pharm. Bull., 2005, 28(1), 101-104.
[http://dx.doi.org/10.1248/bpb.28.101] [PMID: 15635171]
[14]
Ikeda, T.; Yokomizo, K.; Okawa, M.; Tsuchihashi, R.; Kinjo, J.; Nohara, T.; Uyeda, M. Anti-herpes virus type 1 activity of oleanane-type triterpenoids. Biol. Pharm. Bull., 2005, 28(9), 1779-1781.
[http://dx.doi.org/10.1248/bpb.28.1779] [PMID: 16141560]
[15]
Neto, C.C. Ursolic Acid and Other Pentacyclic Triterpenoids: Anticancer Activities and Occurrence in Berries. In: Berries and Cancer Prevention; Stoner, G.D.; Seeram, N.P., Eds.; Springer Science+Business Media: Berlin, 2011.
[http://dx.doi.org/10.1007/978-1-4419-7554-6_2,C_]
[16]
Pan, X.D.; Wang, C.Y. Current status of camptothecin derivatives as natural antitumor agents. Yao Xue Xue Bao, 2003, 38(9), 715-720.
[PMID: 14730926]
[17]
Assefa, H.; Nimrod, A.; Walker, L.; Sindelar, R. Synthesis and evaluation of potential complement inhibitory semisynthetic analogs of oleanolic acid. Bioorg. Med. Chem. Lett., 1999, 9(14), 1889-1894.
[http://dx.doi.org/10.1016/S0960-894X(99)00314-5] [PMID: 10450948]
[18]
Clark, M.; Cramer, R.D., III; Opdenhosch, V.N. Validation of the general purpose tripose 5.2 force field. J. Comput. Chem., 1989, 10, 982-1012.
[http://dx.doi.org/10.1002/jcc.540100804]
[19]
Sun, J.; Cai, S.; Yan, N.; Mei, H. Docking and 3D-QSAR studies of influenza neuraminidase inhibitors using three-dimensional holographic vector of atomic interaction field analysis. Eur. J. Med. Chem., 2010, 45(3), 1008-1014.
[http://dx.doi.org/10.1016/j.ejmech.2009.11.043] [PMID: 19969399]
[20]
Stewart, J.J.P. MOPAC: a semiempirical molecular orbital program. J. Comput. Aided Mol. Des., 1990, 4(1), 1-105.
[http://dx.doi.org/10.1007/BF00128336] [PMID: 2197373]
[21]
Yadav, D.K.; Meena, A.; Srivastava, A.; Chanda, D.; Khan, F.; Chattopadhyay, S.K. Development of QSAR model for immunomodulatory activity of natural coumarinolignoids. Drug Des. Devel. Ther., 2010, 4, 173-186.
[PMID: 20856844]
[22]
Meena, A.; Yadav, D.K.; Srivastava, A.; Khan, F.; Chanda, D.; Chattopadhyay, S.K. In silico exploration of anti-inflammatory activity of natural coumarinolignoids. Chem. Biol. Drug Des., 2011, 78(4), 567-579.
[http://dx.doi.org/10.1111/j.1747-0285.2011.01173.x] [PMID: 21736704]
[23]
Zheng, W.; Tropsha, A. Novel variable selection quantitative structure--property relationship approach based on the k-nearest-neighbor principle. J. Chem. Inf. Comput. Sci., 2000, 40(1), 185-194.
[http://dx.doi.org/10.1021/ci980033m] [PMID: 10661566]
[24]
Kalani, K.; Agarwal, J.; Alam, S.; Khan, F.; Pal, A.; Srivastava, S.K. In silico and in vivo anti-malarial studies of 18β glycyrrhetinic acid from Glycyrrhiza glabra. PLoS One, 2013, 8(9), e74761.
[http://dx.doi.org/10.1371/journal.pone.0074761] [PMID: 24086367]
[25]
Sarfaraz, Alam; Feroz, Khan QSAR and docking studies on xanthone derivatives for anticancer activity targeting DNA topoisomerase IIα. Drug Des. Devel. Ther, 2014, 8, 183-195.
[26]
Gupta, S.; Kalani, K.; Saxena, M.; Srivastava, S.K.; Agrawal, S.K.; Suri, N.; Saxena, A.K. Cytotoxic evaluation of semisynthetic ester and amide derivatives of oleanolic acid. Nat. Prod. Commun., 2010, 5(10), 1567-1570.
[http://dx.doi.org/10.1177/1934578X1000501010] [PMID: 21121249]
[27]
Srivastava, S.K.; Khan, M.; Khanuja, S.P.S. Process for isolation of anticancer agent camptothecin from Nothapodytes Foetida. Patent No. US 6,893,668 B2, 2005.
[28]
Kalani, K.; Yadav, D.K.; Khan, F.; Srivastava, S.K.; Suri, N. Pharmacophore, QSAR, and ADME based semisynthesis and in vitro evaluation of ursolic acid analogs for anticancer activity. J. Mol. Model., 2012, 18(7), 3389-3413.
[http://dx.doi.org/10.1007/s00894-011-1327-6] [PMID: 22271093]
[29]
Yadav, D.K.; Kalani, K.; Singh, A.K.; Khan, F.; Srivastava, S.K.; Pant, A.B. Design, synthesis and in vitro evaluation of 18β-glycyrrhetinic acid derivatives for anticancer activity against human breast cancer cell line MCF-7. Curr. Med. Chem., 2014, 21(9), 1160-1170.
[http://dx.doi.org/10.2174/09298673113206660330] [PMID: 24180274]
[30]
Yadav, D.K.; Kalani, K.; Khan, F.; Srivastava, S.K. QSAR and docking based semi-synthesis and in vitro evaluation of 18 β-glycyrrhetinic acid derivatives against human lung cancer cell line A-549. Med. Chem., 2013, 9(8), 1073-1084.
[http://dx.doi.org/10.2174/1573406411309080009] [PMID: 23675978]
[31]
Srivastava, R.K.; Rahman, Q.; Kashyap, M.P.; Lohani, M.; Pant, A.B. Ameliorative effects of dimetylthiourea and N-acetylcysteine on nanoparticles induced cyto-genotoxicity in human lung cancer cells-A549. PLoS One, 2011, 6(9), e25767.
[http://dx.doi.org/10.1371/journal.pone.0025767] [PMID: 21980536]
[32]
Kashyap, M.P.; Singh, A.K.; Siddiqui, M.A.; Kumar, V.; Tripathi, V.K.; Khanna, V.K.; Yadav, S.; Jain, S.K.; Pant, A.B. Caspase cascade regulated mitochondria mediated apoptosis in monocrotophos exposed PC12 cells. Chem. Res. Toxicol., 2010, 23(11), 1663-1672.
[http://dx.doi.org/10.1021/tx100234m] [PMID: 20957986]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy